Avid Bioservices Inc (CDMO)

[entdoc]

What happens to Roche money flow when Bavi....? Roche=PPHM=Bavi. Among the most incredible attributes of Bavi is that in medium to late-stage disease (cancer) it will be used in conjunction to SOC, and not displace it. Avastin is taking a much-deserved back-seat at this point, but MABs appear to have an rapidly increasing market. Anyone here on top of the MAB market globally? How is China coming along with the Mega-MABreactors we heard were going to on line about now. I suppose that's when we hear results of Cotara vs. lung cancer trials conducted there. How many years has Cotara been approved there for lung cancer, and not a single publication of results, pro- or con. Anyone else think it strange?